Revolutionizing Heart Care: Abbott’s New Leadless Pacemaker in India

Global healthcare leader Abbott has launched the AVEIR DR system in India, marking a significant advancement in cardiac rhythm management. This innovative system represents the world’s first dual chamber leadless pacemaker, offering a wire-free solution for patients needing advanced heart rhythm therapy. Consequently, this breakthrough device is set to transform treatment options for a considerable number of patients across the nation. The AVEIR DR system features two miniaturized leadless pacemakers, each smaller than an AAA battery, communicating wirelessly to synchronize heartbeats.

Understanding Leadless Pacemakers and Their Advantages

Pacemakers play a crucial role in correcting slow heart rhythms, known as bradycardia, by delivering electrical impulses to stimulate a normal heart rate. Traditional pacemakers, however, require wires (leads) that connect the device to the heart, along with a surgical pocket under the skin for the generator. Conversely, leadless pacemakers are implanted directly into the heart via a catheter, eliminating the need for leads and reducing associated risks such as infection or other complications.

Historically, leadless pacemakers could only manage a single chamber of the heart. This limitation meant many patients requiring pacing for both upper and lower heart chambers still needed traditional devices. Fortunately, the development of dual chamber leadless pacemakers addresses this critical gap, providing comprehensive pacing support without the inherent drawbacks of leads.

The AVEIR DR Dual Chamber Leadless Pacemaker Breakthrough

Abbott’s AVEIR DR system utilizes proprietary implant-to-implant (i2i™) communication technology. This allows two distinct leadless pacemakers—one in the right atrium (upper chamber) and another in the right ventricle (lower chamber)—to synchronize in real time. This continuous, beat-to-beat communication between the two devices helps the heart beat more naturally, removing the need for conventional wires. Furthermore, this wireless communication uses high-frequency pulses transmitted through the body’s blood, consuming minimal battery power.

The system consists of the AVEIR VR device for the lower heart chamber and the AVEIR AR for the upper chamber. Each device attaches securely to the heart wall using a small screw-in helix, which also facilitates easy retrieval or replacement if necessary. Furthermore, physicians can perform real-time pacing analysis during implantation, ensuring optimal device positioning before final fixation.

Clinical Efficacy and Safety of the Dual Chamber Leadless Pacemaker

The U.S. FDA approved Abbott’s AVEIR DR system in June 2023, following encouraging results from the AVEIR DR i2i Investigational Device Exemption (IDE) study. The New England Journal of Medicine published these pivotal study findings. The study demonstrated an impressive 98.3% implant success rate, with over 97% of participants achieving normal atrio-ventricular synchrony.

Moreover, the device proved safe and effective across various daily activities, including different postures and gaits. Consequently, the AVEIR DR system offers robust performance, minimizing risks associated with traditional leads, such as pocket hematoma, infection, lead fracture, or dislodgement.

Impact on Indian Patients and Heart Rhythm Management

A significant portion of patients requiring pacemakers in India, nearly one in three, need dual chamber pacing. Therefore, the launch of AVEIR DR expands the benefits of leadless pacing to a broader patient population. Ajay Singh Chauhan, General Manager for Abbott’s Cardiac Rhythm Management business in India, highlighted that this solution is precise, minimally invasive, and technologically advanced for abnormal heart rhythms.

With this launch, Abbott aims to make this cutting-edge leadless pacing technology more accessible to Indian patients who need advanced heart rhythm management solutions. This innovation promises to improve quality of life by reducing discomfort, eliminating surgical scars, and removing arm movement restrictions often associated with traditional pacemaker implantation.

Frequently Asked Questions

Q1: What is a dual chamber leadless pacemaker?

A dual chamber leadless pacemaker consists of two small, wire-free devices implanted directly into the heart’s upper and lower chambers. These devices communicate wirelessly to synchronize heartbeats, mimicking the natural rhythm, without the need for traditional leads or a surgical pocket.

Q2: What are the main benefits of the Abbott AVEIR DR system compared to traditional pacemakers?

The main benefits include eliminating leads and surgical pockets, which reduces risks like infection and lead-related complications. It also offers a minimally invasive procedure, quicker recovery, no visible scarring, and fewer post-implantation activity restrictions.

Q3: Is the AVEIR DR dual chamber leadless pacemaker approved in India?

Yes, Abbott has announced the launch of the AVEIR DR system in India, making it available for patients needing dual chamber pacing. This follows its U.S. FDA approval in June 2023.

References

1. Abbott Launches World’s First Dual Chamber Leadless Pacemaker in India – ETHealthworld
2. Abbott launches world’s first dual-chamber leadless pacemaker system in India. (2025, October 6). *ANI*. Retrieved from https://www.aninews.in/news/business/business/abbott-launches-worlds-first-dual-chamber-leadless-pacemaker-system-in-india20251006151044/
3. Abbott tout results from AVEIR DR pacemaker trial. (2023, May 22). *Medical Device Network*. Retrieved from https://www.medicaldevice-network.com/news/abbott-aveir-dr-pacemaker-trial-results/
4. Aveir DR Dual-Chamber Leadless Pacemaker Looks Solid at 1 Year. (2024, May 23). *TCTMD.com*. Retrieved from https://www.tctmd.com/news/aveir-dr-dual-chamber-leadless-pacemaker-looks-solid-1-year
5. Leadless dual-chamber pacemaker is a leap forward for heart patients. (2024, May 24). *UT Southwestern Medical Center*. Retrieved from https://www.utsouthwestern.edu/newsroom/articles/year-2024/dual-chamber-leadless-pacemaker.html
6. Leadless Pacemaker Provides Wireless Heart Rhythm Options—Without Open Surgery. (2024, February 2). *MedStar Health*. Retrieved from https://www.medstarhealth.org/blog/leadless-pacemaker-wireless-heart-rhythm
7. Stanford Health Care Successfully Implants Leadless Dual Chamber Pacemaker. (2024, August 15). *Stanford Health Care*. Retrieved from https://stanfordhealthcare.org/content/stanfordhealthcare/en/newsroom/articles/2024/stanford-health-care-successfully-implants-leadless-dual-chamber-pacemaker.html
8. AVEIR Dual Chamber Leadless Pacemaker Now FDA Approved. (2023, September 26). *Abbott*. Retrieved from https://www.cardiovascular.abbott/us/en/hcp/products/electrophysiology/aveir/dual-chamber-leadless-pacemaker-fda-approved.html
9. First Dual-Chamber Leadless Pacemaker Surpasses Safety and Performance Goals at 90 Days. (2023, June 12). *Cleveland Clinic Consult QD*. Retrieved from https://consultqd.clevelandclinic.org/first-dual-chamber-leadless-pacemaker-surpasses-safety-and-performance-goals-at-90-days/
10. Abbott Introduces Leadless Pacemaker in India for Treating Slow Heart Rhythms. (2024, November 25). *eHealth Network*. Retrieved from https://ehealth.eletsonline.com/2024/11/abbott-introduces-leadless-pacemaker-in-india-for-treating-slow-heart-rhythms/
11. Abbott Launches Leadless Pacemaker in India for Slow Heart Rhythms. (2024, December 5). *Zee Business*. Retrieved from https://www.zeebiz.com/companies/news-abbott-launches-leadless-pacemaker-in-india-for-slow-heart-rhythms-271387

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.